Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3p7c | P7C | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3p7c | P7C | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 3p7b | P7B | Mitogen-activated protein kinase 14 | / | 0.723 | |
| 2yis | YIS | Mitogen-activated protein kinase 14 | / | 0.666 | |
| 3o8u | BMU | Mitogen-activated protein kinase 14 | / | 0.625 | |
| 3p7a | P7A | Mitogen-activated protein kinase 14 | / | 0.621 | |
| 1kv2 | B96 | Mitogen-activated protein kinase 14 | / | 0.605 | |
| 3lfb | Z87 | Mitogen-activated protein kinase 14 | / | 0.596 | |
| 3hv6 | R39 | Mitogen-activated protein kinase 14 | / | 0.584 | |
| 3uvr | 06F | Mitogen-activated protein kinase 14 | / | 0.538 | |
| 1kv1 | BMU | Mitogen-activated protein kinase 14 | / | 0.528 | |
| 3d83 | GK6 | Mitogen-activated protein kinase 14 | / | 0.522 | |
| 3gcu | R48 | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 3gcv | SS6 | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 4eh9 | 0OQ | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 3nnx | EDD | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 1wbs | LI2 | Mitogen-activated protein kinase 14 | / | 0.508 | |
| 3p5k | P5K | Mitogen-activated protein kinase 14 | / | 0.503 | |
| 1wbv | LI3 | Mitogen-activated protein kinase 14 | / | 0.501 | |
| 3p79 | P79 | Mitogen-activated protein kinase 14 | / | 0.501 | |
| 3nnw | EDD | Mitogen-activated protein kinase 14 | / | 0.493 | |
| 2e2b | 406 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.491 | |
| 5hid | B1E | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.487 | |
| 1w82 | L10 | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 3nnu | EDB | Mitogen-activated protein kinase 14 | / | 0.482 | |
| 1wbn | L09 | Mitogen-activated protein kinase 14 | / | 0.477 | |
| 3lff | Z83 | Mitogen-activated protein kinase 14 | / | 0.475 | |
| 1wbt | WBT | Mitogen-activated protein kinase 14 | / | 0.474 | |
| 3vhe | 42Q | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.471 | |
| 3gcs | BAX | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 2yiw | YIW | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 3npc | B96 | Mitogen-activated protein kinase 9 | 2.7.11.24 | 0.462 | |
| 2hyy | STI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.457 | |
| 2hiw | 7MP | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.456 | |
| 3qw2 | NAD | Myo-inositol-1-phosphate synthase (Ino1) | / | 0.454 | |
| 2vo0 | M03 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.450 | |
| 1wbw | LI4 | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3e93 | 19B | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 4h1m | 0YJ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.446 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
| 2v51 | LAB | Actin, alpha skeletal muscle | / | 0.444 | |
| 4b1u | LAB | Actin, alpha skeletal muscle | / | 0.444 | |
| 4hw7 | 64M | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.444 | |
| 3hv7 | 1AU | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 3ldg | SAH | Uncharacterized protein | / | 0.443 | |
| 3wze | BAX | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.443 | |
| 2hzn | KIN | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.441 | |
| 3gi3 | B10 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.440 |